Skip to main content

Advertisement

SpringerLink
Log in

Neuroendocrine dysfunction in fibromyalgia and migraine

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Fibromyalgia (FM) and migraine are common chronic disorders that predominantly affect women. The prevalence of headache in patients with FM is high (35%–88%), with migraine being the most frequent type. A particular subgroup of patients with FM (approximately half) presents with a combined clinical form of these two painful disorders, which may exhibit a different manner of progression regarding symptomatology and impact on daily activities. This article reviews several common aspects of the pathophysiology regarding pain control mechanisms and neuroendocrine dysfunction occurring in FM and migraine, particularly in the chronic form of the latter. We also discuss the participation of hypothalamic and brainstem centers of pain control, the putative role played by neurotransmitters or neuromodulators on central sensitization, and changes in their levels in the cerebrospinal fluid. Understanding their mechanisms will help to establish new treatment strategies for treating these disabling brain disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wolfe F, Ross K, Anderson J, et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19–28.

    Article  PubMed  CAS  Google Scholar 

  2. Thompson D, Lettich L, Takeshita J: Fibromyalgia: an overview. Curr Psychiatry Rep 2003, 5:211–217.

    Article  PubMed  Google Scholar 

  3. Bradley LA: Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 2008, 69(Suppl 2):6–13.

    PubMed  CAS  Google Scholar 

  4. Stuginski-Barbosa J, Dach F, Speciali JG: Relationship between primary headache and fibromyalgia: literature review (in Portuguese). Rev Bras Reumatol 2007, 47:114–120.

    Article  Google Scholar 

  5. Tommaso M, Sardaro M, Serpino C, et al.: Fibromyalgia comorbidity in primary headaches. Cephalalgia 2009, 29:453–464.

    Article  PubMed  Google Scholar 

  6. Ifergane G, Buskila D, Simiseshvely N, et al.: Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2006, 26:451–456.

    Article  PubMed  CAS  Google Scholar 

  7. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992, 35:550–556.

    Article  PubMed  CAS  Google Scholar 

  8. Schweinhardt P, Sauro KM, Bushnell MC: Fibromyalgia: a disorder of the brain? Neuroscientist 2008, 14:415–421.

    Article  PubMed  Google Scholar 

  9. Gur A, Oktayoglu P: Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des 2008, 14:1274–1294.

    PubMed  CAS  Google Scholar 

  10. Jones KD, Deodhar P, Lorentzen A, et al.: Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum 2007, 36:357–379.

    Article  PubMed  CAS  Google Scholar 

  11. Kuchinad A, Schweinhardt P, Seminowicz DA, et al.: Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 2007, 27:4004–4007.

    Article  PubMed  CAS  Google Scholar 

  12. Vaerøy H, Sakurada T, Førre O, et al.: Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol Suppl 1989, 19:94–97.

    PubMed  Google Scholar 

  13. Sarchielli P, Alberti A, Candeliere A, et al.: Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 2006, 26:409–415.

    Article  PubMed  CAS  Google Scholar 

  14. Neeck G, Crofford LJ: Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000, 26:989–1002.

    Article  PubMed  CAS  Google Scholar 

  15. Nielsen LA, Henriksson KG. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Pract Res Clin Rheumatol 2007, 21:465–480.

    Article  PubMed  Google Scholar 

  16. Wolfe F, Smythe H, Yunus M, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990, 33:160–172.

    Article  PubMed  CAS  Google Scholar 

  17. Farias da Silva W, Sampaio M, Costa Neto J, et al.: Migranea. Rio de Janeiro: Sociedade Brasileira de Cefaléia; 2005.

    Google Scholar 

  18. Goadsby PJ: Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2007, 13:39–44.

    Article  PubMed  CAS  Google Scholar 

  19. Ambrosini A, Schoenen J: Electrophysiological response patterns of primary sensory cortices in migraine. J Headache Pain 2006, 7:377–388.

    Article  PubMed  Google Scholar 

  20. McDermid AJ, Rollman GB, McCain GA: Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 1996, 66:133–144.

    Article  PubMed  CAS  Google Scholar 

  21. Gracely RH, Petzke F, Wolf JM, et al.: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333–1343.

    Article  PubMed  Google Scholar 

  22. Staud R: Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther 2006, 8:208.

    Article  PubMed  Google Scholar 

  23. Bradley LA: Pathophysiologic mechanisms of fibromyalgia and its related disorders. Clin Psychiatry 2008, 69(Suppl 2):6–13.

    CAS  Google Scholar 

  24. Anderberg UM, Marteinsdottir I, Theorell T, et al.: The impact of life events in female patients with fibromyalgia and in female healthy controls. Eur Psychiatry 2000, 15:295–301.

    Article  PubMed  CAS  Google Scholar 

  25. Cohen H, Neumann L, Haiman Y, et al.: Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 2002, 32:38–50.

    Article  PubMed  Google Scholar 

  26. Amital D, Fostick L, Polliack ML, et al.: Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 2006, 61:663–669.

    Article  PubMed  Google Scholar 

  27. López-Jiménez M, Valença MM, Moreira AC, Antunes-Rodrigues J: Ether and immobilization stress effects on pituitary adrenal function in hemidecorticate rats. Braz J Med Biol Res 1989, 22:779–782.

    PubMed  Google Scholar 

  28. Negro-Vilar A, Johnston C, Spinedi E, et al.: Physiological role of peptides and amines on the regulation of ACTH secretion. Ann N Y Acad Sci 1987, 512:218–236.

    Article  PubMed  CAS  Google Scholar 

  29. Okifuji A, Bradshaw DH, Olson C: Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol 2009, 28:475–478.

    Article  PubMed  Google Scholar 

  30. Macedo JA, Hesse J, Turner JD, et al.: Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 2008, 33:799–809.

    Article  PubMed  CAS  Google Scholar 

  31. Cortelli P, Pierangeli G: Hypothalamus and headaches. Neurol Sci 2007, 28:S198–S202.

    Article  PubMed  Google Scholar 

  32. Peres MF, Sanchez del Rio M, Seabra ML, et al.: Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001, 71:747–751.

    Article  PubMed  CAS  Google Scholar 

  33. Valença MM, Andrade-Valença LP, da Silva WF, Dodick DW: Hemicrania continua secondary to an ipsilateral brainstem lesion. Headache 2007, 47:438–441.

    PubMed  Google Scholar 

  34. Giffin NJ, Ruggiero L, Lipton RB, et al.: Premonitory symptoms in migraine: an electronic diary study. Neurology 2003, 60:935–940.

    PubMed  CAS  Google Scholar 

  35. Lipton RB, Bigal ME: Migraine and Other Headache Disorders, edn 1. New York: Informa Healthcare; 2006:529.

    Google Scholar 

  36. Kelman L: The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004, 44:865–872.

    Article  PubMed  Google Scholar 

  37. Vaeroy H, Helle R, Førre O, et al.: Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988, 15:1804–1806.

    PubMed  CAS  Google Scholar 

  38. Buskila D, Sarzi-Puttini P, Ablin JN: The genetics of fibromyalgia syndrome. Pharmacogenomics 2007, 8:67–74.

    Article  PubMed  CAS  Google Scholar 

  39. Cuadrado ML, Young WB, Fernández-de-las-Peñas C, et al.: Migrainous corpalgia: body pain and allodynia associated with migraine attacks. Cephalalgia 2008, 28:87–91.

    PubMed  CAS  Google Scholar 

  40. Papageorgiou AC, Silman AJ, Macfarlane GJ: Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002, 61:1071–1074.

    Article  PubMed  CAS  Google Scholar 

  41. Vieira DS, Naffah-Mazzacoratti G, Zukerman E, et al.: Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Headache 2007, 47:842–847.

    Article  PubMed  Google Scholar 

  42. Sarchielli P, Mancini ML, Floridi A, et al.: Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 2007, 8:737–745.

    Article  PubMed  CAS  Google Scholar 

  43. Russo EB: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 2004, 25:31–39.

    PubMed  CAS  Google Scholar 

  44. Obermann M, Gizewski ER, Limmroth V, et al.: Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia 2006, 26:763–766.

    Article  PubMed  CAS  Google Scholar 

  45. Ifergane G, Shelef I, Buskila D: Migraine and fibromyalgia developing after a pontine haemorrhage. Cephalalgia 2007, 27:191.

    Article  PubMed  Google Scholar 

  46. Gunduz B, Bayazit YA, Celenk F, et al.: Absence of contralateral suppression of transiently evoked otoacoustic emissions in fibromyalgia syndrome. J Laryngol Otol 2008, 122:1047–1051.

    Article  PubMed  CAS  Google Scholar 

  47. Heffez DS, Ross RE, Shade-Zeldow Y, et al.: Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications. Eur Spine J 2007, 16:1423–1433.

    Article  PubMed  Google Scholar 

  48. Dodick D, Silberstein S: Central sensitization theory of migraine: clinical implications. Headache 2006, 46:S182–S191.

    Article  PubMed  Google Scholar 

  49. Peres MF: Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 2005, 25:403–411.

    Article  PubMed  CAS  Google Scholar 

  50. Reiter RJ, Acuna-Castroviejo D, Tan DX: Melatonin therapy in fibromyalgia. Curr Pain Headache Rep 2007, 11:339–342.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Israelita deEnsino e Pesquisa Hospital Albert Einstein, Al Joaquim Eugenio de Lima, 881 cj 708, 01403-001, Sao Paulo, Brazil

    Mario F. P. Peres

Authors
  1. Marcelo Moraes Valença
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabíola Lys Medeiros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hugo A. Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rodrigo Meirelles Massaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mario F. P. Peres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario F. P. Peres.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valença, M.M., Medeiros, F.L., Martins, H.A. et al. Neuroendocrine dysfunction in fibromyalgia and migraine. Current Science Inc 13, 358–364 (2009). https://doi.org/10.1007/s11916-009-0058-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-009-0058-1

Keywords

Search

Navigation